New Zealand's biotech industry is flourishing and the government is dedicated to speeding up the development of this knowledge based industry. The opportunities for investors will continue to grow as a result of the government taking a series of positive steps to promote the growth. It has...
A pioneering inventiveness and scientific expertise has been at the core of NZ’s prowess in the biotechnology industry. New Zealand is competitive in the global market as a prime biotechnology sector in the world. It has excelled in genomics, biopharmaceuticals, diagnostics, nutraceuticlas and...
The Malaghan Institute of Medical Research will lead a $5 million research in therapeutic cancer vaccines. This investment into R&D by the Health Council of New Zealand (HRC) is expected to last for three to four years. It makes up for one of the main winners in an $81.88 million financing...
Genesis Research and Development Corp., an Auckland based biotechnology company reported it had found a viable New Zealand investor and may rethink its decision to move its operations overseas. The company’s CEO, Stephen Halls, said Tuesday that the company expects to conclude the placement of 7.4...